- Oral presentation
- Open Access
7.4 Improvements in individual disease components are sustained with long-term adalimumab therapy for polyarticular Juvenile Idiopathic Arthritis
© Ruperto et al; licensee BioMed Central Ltd. 2008
- Published: 15 September 2008
- Juvenile Idiopathic Arthritis
- Passive Motion
- Health Assessment Questionnaire
- Joint Involvement
Improvements in JIA with adalimumab therapy
Improvement at Week 56 of OLE
Long-term treatment with adalimumab substantially improves multiple aspects of polyarticular JIA.
This article is published under license to BioMed Central Ltd.